bluebird bio, Inc.
(NASDAQ:BLUE)
$2.86
-1.95 (-40.54%)
Open: 1:00 PM
BLUE Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
BLUE Stock Price Today
bluebird bio, Inc. (BLUE) stock declined over -40.54% intraday to trade at $2.86 a share on NASDAQ. The stock opened with a loss of -35.34% at $3.11 and touched an intraday high of $3.11, falling -40.54% against the last close of $4.81. The bluebird bio, Inc. in stock market went to a low of $2.69 during the session.
BLUE Stock Snapshot
$4.81
Prev. Close
312.71 Million
Market Cap
$2.69
Day Low
$3.11
Open
N/A
Number of Shares
$3.11
Day High
N/A
P/E ratio
-0.74
EPS (TTM)
1.59
Cash Flow per Share
N/A
Free Float in %
2.08
Book Value
51855597.00
Volume
BLUE Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta0.95
Sales or Revenue$21.73 Million
5Y Sales Change-13.17%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.
Peers
Frequently Asked Questions
What is the current bluebird bio, Inc. (BLUE) stock price?
bluebird bio, Inc. (NASDAQ: BLUE) stock price is $2.86 in the last trading session. During the trading session, BLUE stock reached the peak price of $3.11 while $2.69 was the lowest point it dropped to. The percentage change in BLUE stock occurred in the recent session was -40.54% while the dollar amount for the price change in BLUE stock was -$1.95.
BLUE's industry and sector of operation?
The NASDAQ listed BLUE is part of Biotechnology industry that operates in the broader Healthcare sector. bluebird bio, Inc. , a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases.
Who are the executives of BLUE?
Sarah Alspach
Chief Communications Officer
Dr. Liviu Niculescu M.D., Ph.D.
Senior Vice President of Global Medical Affairs
Ms. Melissa Bonner
Senior Vice President of Research
Mr. Thomas J. Klima
Chief Commercial Officer & Chief Operating Officer
How BLUE did perform over past 52-week?
BLUE's closing price is 0.54% higher than its 52-week low of $2.52 where as its distance from 52-week high of $8.58 is -0.50%.
How many employees does BLUE have?
Number of BLUE employees currently stands at N/A. BLUE operates from 60 Binney Street, Cambridge, MA 02142, US.
Link for BLUE official website?
Official Website of BLUE is: https://www.bluebirdbio.com
How do I contact BLUE?
BLUE could be contacted at phone #339 499 9300 and can also be accessed through its website. BLUE operates from 60 Binney Street, Cambridge, MA 02142, US.
How many shares of BLUE are traded daily?
BLUE stock volume for the day was 51855597.00 shares. The average number of BLUE shares traded daily for last 3 months was 3.84 Million.
What is the market cap of BLUE currently?
The market value of BLUE currently stands at $312.71 Million with its latest stock price at $2.86 and N/A of its shares outstanding.